Subscribe
Sign in
Home
Notes
Idea Archive
Portfolio
Philosophy
Disclaimer
About
Latest
Top
Discussions
Why Your Hit Rate Doesn't Matter (And What Actually Does)
The maths behind the world's best investors prove that being right isn't the game. Being right big is.
14 hrs ago
•
Schwar Capital Research
7
1
The Art of Risk Taking
What an ancient military treatise taught me about asymmetric investing.
Apr 6
•
Schwar Capital Research
11
2
1
Q1 2026 Roundup
Happy Easter weekend to everyone celebrating - and happy long weekend to everyone else.
Apr 3
•
Schwar Capital Research
7
2
March 2026
EPS Up 100%, 2.8x EV/EBITDA, and 4.5x Upside If the Optionality Hits
The most asymmetric setup in the portfolio just got stronger.
Mar 30
•
Schwar Capital Research
5
1
March Portfolio Update
Up 1.2% year-to-date versus -6.4% for the S&P 500. Here's what I'm doing...
Mar 27
•
Schwar Capital Research
4
1
New Position: Lottery Ticket With 12x Upside Potential
1 day until the catalyst. A 1% portfolio position with asymmetric upside and a single binary event tomorrow.
Mar 25
•
Schwar Capital Research
17
5
1
Two Companies I Think The Market Is Mispricing (AT.L, PPIH)
Ashtead Technology delivers FY25 results ahead of expectations at 8x earnings. Perma-Pipe quietly pivots into AI data center infrastructure while…
Mar 23
•
Schwar Capital Research
5
1
TruFin Final Results: Every Line Beat, the Operating Leverage Is Real (TRU.L)
Audited numbers confirm it. This business is scaling while returning cash to shareholders.
Mar 20
•
Schwar Capital Research
5
1
My Top 8 Highest Conviction Micro Cap Ideas
We are nearly a Substack Bestseller!
Mar 16
•
Schwar Capital Research
27
2
3
KFS Q4 2025: The J-Curve Is Turning
KSX revenue up 64%, sequential EBITDA improving every quarter, double-digit organic growth budgeted for 2026. The thesis is playing out.
Mar 13
•
Schwar Capital Research
6
1
15 Microcap Ideas on My Watchlist
Monopolies, turnarounds, and regulatory tailwinds the market hasn't priced in yet.
Mar 9
•
Schwar Capital Research
11
3
ACFN Q4 2025: Down 15% on Record Margins.
Record margins, 22% monitoring growth, a sleeper catalyst the market hasn't priced in. The selloff is overdone.
Mar 6
•
Schwar Capital Research
4
1
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts